STOCKHOLDERS' EQUITY

6 Months Ended

Jun. 30, 2025

STOCKHOLDERS' EQUITY

STOCKHOLDERS' EQUITY

(5) STOCKHOLDERS' EQUITY

Earnings (Loss) Per Share

Basic earnings (loss) per share has been computed by dividing earnings (loss) available to common stockholders by the weighted average number of common shares outstanding during the respective period. Diluted earnings (loss) per share has been computed by dividing earnings (loss) available to common stockholders by the weighted average shares outstanding during the respective period, after adjusting for the potential dilution of options to purchase the Company’s common stock, assumed vesting of restricted stock units and the assumed conversion of the Company’s convertible debt, if such conversion would be dilutive.

The following table provides the computation of diluted earnings and diluted weighted average number of common shares outstanding:

(in millions)		Three Months Ended June 30,				Six Months Ended June 30,
		2025		2024		2025		2024
Computation of diluted earnings:
Net income	$	97.6	$	83.1	$	136.0	$	109.3
Add: Interest expense from assumed conversion of convertible notes, net of tax		0.1		1.0		1.0		2.0
Net income for diluted earnings per share calculation	$	97.7	$	84.1	$	137.0	$	111.3
Computation of diluted weighted average shares outstanding:
Basic weighted average shares outstanding		42,321,267		45,429,998		42,999,281		45,623,470
Incremental shares from assumed exercise of stock options and vesting of restricted stock units		457,241		488,454		330,406		423,354
Incremental shares from assumed conversion of convertible debt		176,123		2,781,818		1,188,445		2,781,818
Diluted weighted average shares outstanding		42,954,631		48,700,270		44,518,132		48,828,642

The table includes all stock options and restricted stock units that are dilutive to the Company's weighted average common shares outstanding during the period. The calculation of diluted earnings per share excludes stock options or shares of restricted stock units that are anti-dilutive to the Company's weighted average common shares outstanding of approximately 3.9 million and 3.9 million for the three and six months ended June 30, 2025 and 3.1 million and 3.2 million for the three and six months ended June 30, 2024, respectively.

Euronet issued Convertible Senior Notes ("Convertible Notes") due March 2049 on March 18, 2019. The Convertible Notes currently have a settlement feature requiring us upon conversion to settle the principal amount of the debt and any conversion value in excess of the principal value ("conversion premium"), for cash or shares of Euronet's common stock or a combination thereof, at the Company's option. The Company has stated its intent to settle any conversion of these notes by paying cash for the principal value and issuing common stock for any conversion premium; however, after adopting ASU 2020-06, 2.8 million incremental shares assumed for conversion of Convertible Notes were initially required to be included in the dilutive earnings per share calculation, if dilutive, regardless of whether the market price trigger had been met. Therefore, the Convertible Notes are included in the calculation of diluted earnings per share if their inclusion is dilutive. The dilutive effect increases the more the market price exceeds the conversion price of $188.73 per share. See Note 10, Debt Obligations, to the consolidated financial statements for more information about the Convertible Notes.

During March 2025, almost all of the Convertible Note holders exercised their right to require the Company to repurchase their notes, and the Company repurchased $491.8  million of Convertible Notes leaving $33.2 million of Convertible Notes outstanding at June 30, 2025. This repurchase reduced the weighted average incremental shares from assumed conversion from 2.8 million in the prior year to 0.2 million for the three months ended June 30, 2025.

Share repurchases

On September 13, 2023, the Company put a repurchase program in place to repurchase up to $350 million in value, but not more than 7.0 million shares of common stock through September 13, 2025. As of June 30, 2025, no shares were available to be repurchased under this repurchase program. 

On September 11, 2024, the Company put a repurchase program in place to repurchase up to $350 million in value, but not more than 7.0 million shares of common stock through September 11, 2026. As of June 30, 2025, approximately $224.8 million in value of additional shares were available to be repurchased under this repurchase program. 

On June 3, 2025, the Company put a repurchase program in place to repurchase up to $400 million in value, but not more than 8.0 million shares of common stock through June 3, 2027. As of June 30, 2025, all shares were available to be repurchased under this repurchase program. 

Repurchases under the programs may take place in the open market or in privately negotiated transactions, including derivative transactions, and may be made under a Rule 10b5-1 plan.

Accumulated Other Comprehensive Income (loss)

Accumulated other comprehensive income (loss) consists entirely of foreign currency translation adjustments. The Company recorded foreign currency translation gains of $186.0 million and $270.0 million for the three and six months ended June 30, 2025 and losses of $10.0 million and $55.0 million for the three and six months ended June 30, 2024, respectively. There were no reclassifications of foreign currency translation adjustments into the consolidated statements of income for the three and six months ended June 30, 2025 and 2024.